Skip to main content

Day: February 27, 2026

Investment Company AB Tewox acquires a retail park in Poland

Vilnius, Lithuania, Feb. 27, 2026 (GLOBE NEWSWIRE) — AB Tewox, managed by Lords LB Asset Management, continues to expand its retail real estate portfolio in Poland with the acquisition of a retail park in Konin that was opened in 2023.  The total leasable area of the property is approximately 5,440 sq. m. The seller is Dekada Konin – a development company established by Dekada S.A., an investor operating in the commercial real estate market in Poland, and Xcity Investment Sp. z o.o. from the PKP S.A. Group. The value of the transaction has not been disclosed; the acquisition was financed by Deutsche Pfandbriefbank (pbb).  The retail park is situated in the central part of Konin, integrated with the train station in a high-traffic zone. The property has strong tenants like Biedronka, Pepco, Rossmann, TEDi and others.  Following...

Continue reading

FRO – Fourth Quarter and Full Year 2025 Results

FRONTLINE PLC REPORTS RESULTS FOR THE FOURTH QUARTER ENDED DECEMBER 31, 2025 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three and twelve months ended December 31, 2025: HighlightsProfit of $227.9 million, or $1.02 per share for the fourth quarter of 2025. Adjusted profit of $230.4 million, or $1.03 per share for the fourth quarter of 2025. Declared a cash dividend of $1.03 per share for the fourth quarter of 2025. Reported revenues of $624.5 million for the fourth quarter of 2025. Achieved average daily spot time charter equivalent earnings (“TCEs”)1 for VLCCs, Suezmax tankers and LR2/Aframax tankers in the fourth quarter of $74,200, $53,800 and $33,500 per day, respectively. Entered into agreements to sell eight of our oldest first-generation ECO VLCCs, built...

Continue reading

Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy

Pratteln, Switzerland, February 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE® (vamorolone), in the pharmaceutical coverage of the Spanish National Health System, making it eligible for reimbursement. The conditions for such inclusion will be determined in a resolution by the Directorate-General of Pharmacy at the Spanish Ministry of Health. The company expects to receive the draft of such resolution shortly. Once the company accepts the draft, the product will be included in the database of products financed by the National Health System in Spain. Assuming this process proceeds along typical timelines, Santhera plans to start to make the product available across the various regions in Spain from early in the second quarter...

Continue reading

13/2026・Trifork Group: 2025 annual report and interim report for the quarter ending 31 December 2025

Schindellegi, Switzerland – 27 February 2026 Trifork Group AGCompany announcement no. 13/2026 2025 annual report and interim report for the quarter ending 31 December 2025 Trifork Group reports full-year 2025 revenue growth of 7.2% and adj. EBITDA margin of 13.6% with accelerated organic revenue growth and strong margin improvement in the fourth quarter. A EURm 10 share buyback will be initiated. A strategic review of options for Trifork Labs has been initiated. Comment from Group CEO Jørn Larsen “We delivered solid organic growth of 7.0% in 2025 and 9.4% in Q4. As expected, margins improved toward year-end, and we finished within the full-year guidance set a year ago. We expect the positive momentum to continue in 2026, with record revenue and profits. As part of our product-led transition, we have introduced a new reporting structure...

Continue reading

Lassila & Tikanoja Plc Financial Statements Release January – December 2025

Lassila & Tikanoja PlcStock exchange release 27 February 2026 at 8.00 AM EET OPERATIONS AS AN INDEPENDENT LISTED COMPANY BEGAN, SOLID PERFORMANCE CONTINUED The financial information presented in this Financial Statements Release is based on actual figures as at 31 December 2025 for the statement of financial position, and on carve‑out financial information for other financial information and comparative periods. The carve‑out financial information does not necessarily reflect what the combined results of operations, financial position or cash flows would have been had Lassila & Tikanoja operated as an independent legal group and prepared separate consolidated financial information for the periods presented. Nor does the carve‑out financial information necessarily indicate the future results of operations, financial position or...

Continue reading

Luotea’s Financial Statements Release 2025: The partial demerger was completed at year end; significant profitability improvement in continuing operations in 2025

Luotea PlcStock exchange release27 February 2026 at 8:00 a.m Luotea Plc: Financial Statements Release 1 January – 31 December 2025 The partial demerger was completed at year‑end; significant profitability improvement in continuing operations in 2025 The Circular economy business of Lassila & Tikanoja Plc was separated on 31 December 2025 through a partial demerger into an independent company, which was named the New Lassila & Tikanoja Plc. Luotea Plc continues the Facility Services Business. The company’s Extraordinary General Meeting approved the partial demerger on 4 December 2025. In this financial statement release, Luotea Plc presents the Circular Economy Business as Discontinued Operations in accordance with IFRS 5. Comparative periods have been adjusted accordingly. Presentation in accordance with IFRS 5 does not reflect...

Continue reading

Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)

Dear shareholder, Dear Madam, Dear Sir,Please find attached our press release with the FY2025 Results:Outstanding results at DEME, Delen Private Bank, Bank Van Breda and SIPEF boost net profit to 592.5 million euros. Equity strengthens to 5.7 billion euros, delivering a 10.3% return on equity Proposal to increase the dividend to 4.60 euros per share (+21%)Best regards Ackermans & van HaarenAttachmentAvH ends a successful year 2025 with a net profit of 593 million euros

Continue reading

15/2026・Trifork Group: Initiation of share buyback program

Schindellegi, Switzerland – 27 February 2026 Trifork Group AGCompany announcement no. 15/2026 Initiation of share buyback program Today, Trifork Group AG (“Trifork”) announces that the Board of Directors has decided to initiate a share buyback program of up to DKK 75 million (approximately EUR 10 million). The share buyback program is initiated pursuant to the decision of the Board of Directors taken on 27 February 2026 to acquire own registered shares with a nominal value of CHF 0.10 each. The purpose of the program is to reduce the share capital in order to redistribute excess cash to shareholders, by cancellation of shares, if and to the extent so decided in the future by the Board of Directors, by use of the capital band set forth in the Articles of Association of Trifork, which were approved by the Annual General Meeting on 12 April...

Continue reading

14/2026・Trifork Group: Changes to the Board of Directors

Schindellegi, Switzerland – 27 February 2026 Trifork Group AGCompany announcement no. 14/2026 Changes to the Board of Directors With the ending annual cycle 2025, Julie Galbo and Maria Hjorth have decided not to stand for re-election at the upcoming AGM, as they wish to focus on other professional commitments. Having served on the Board for nearly six years, including through the IPO process, Julie and Maria have played an important role in Trifork’s development. During their tenure, Trifork has nearly doubled its revenue and EBITDA. The Board of Directors and Executive Management express their highest appreciation for their service and thank them for their dedication and efforts on behalf of Trifork. At the upcoming AGM, the Board of Directors will propose Anja Monrad as new member and chairperson and Danny Lange as new member to the...

Continue reading

Lassila & Tikanoja Plc to launch a share repurchase programme for share‑based incentive schemes and remuneration of the Board of Directors

Lassila & Tikanoja PlcStock exchange release27 Feb 2026 at 7.50 AM EET Lassila & Tikanoja Plc to launch a share repurchase programme for share‑based incentive schemes and remuneration of the Board of Directors The Board of Directors of Lassila & Tikanoja Plc has decided to exercise the authorisation granted by the Extraordinary General Meeting held on 4 December 2025 to repurchase the Company’s own shares. The repurchase of shares will commence at the earliest on 2 March 2026 and end at the latest on 28 April 2026. The maximum number of shares to be repurchased is 150,000, representing approximately 0.39 per cent of all shares in Lassila & Tikanoja Plc. The shares will be repurchased for the purposes of implementing the Company’s share‑based incentive schemes and remuneration of the Board of Directors. The Company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.